Status:
UNKNOWN
Study on the Risks of Symptomatic Dengue on Pregnancy
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Dengue
Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
Dengue fever is the most common arbovirus worldwide (390 million people infected per year) and is a global public health problem. This public health problem is also becoming European due to its rapid ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for the case :
- Pregnant patients
- Major
- Affiliated with social security
- Symptomatic or pauci-symptomatic dengue
- Biological confirmation of dengue fever
- Inclusion Criteria for the control :
- Pregnant patients
- Major
- Affiliated with social security
- Asymptomatic
- Exclusion Criteria for the 2 group :
- Multiple pregnancy
- Patient's refusal
- Protected persons: person deprived of liberty by judicial or administrative decision, minor, and person subject to a legal protection measure: guardianship or curators)
Exclusion
Key Trial Info
Start Date :
June 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
336 Patients enrolled
Trial Details
Trial ID
NCT04826081
Start Date
June 15 2021
End Date
March 1 2024
Last Update
November 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Réunion
Saint-Pierre, France, 97448